Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced a recent commercial agreement with Success TMS in which Success TMS will exclusively utilize Neuronetics’ platform, NeuroStar Advanced Therapy for Mental Health, …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar® Advanced Therapy for Mental Health than with TMS treatments that claim deeper …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced its new website to meet consumer demand for information on accessing advanced treatments for depression. The enhanced site also makes it easier …
Read More
Our nation reported more mental health stress in 2020, but there was not a corresponding increase in people seeking mental health treatment, according to the inaugural State of the Nation’s …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on patients who suffer from psychiatric disorders, is honoring the depression journeys of its employees and …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer …
Read More
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, announced the publication …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from …
Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the U.S. Food and Drug Administration (FDA) granted clearance for the Company’s TouchStar treatment, a three-minute intermittent theta burst (iTBS) protocol …
Read More